AIM reversal: CRISM Therapeutics brain cancer treatment potential

Brain tumour treatment developer Extruded Pharmaceuticals reversed into Amur Minerals Corporation, which had sold its mining asset and become a shell, to form CRISM Therapeutics Corporation on 31 May. There was a one-for-160 share consolidation prior to the readmission.

The shell had cash in it, but it will not last long. Management believes that there is enough to start a phase II clinical trial for the ChemoSeed implantable, bioresorbable drug delivery platform.

The opening share price ...

You are unauthorized to view this page.

Latest News

More Articles Like This

Tagdiv Cloud library - template content.